サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1221054

経口高分子製剤の世界市場：成長を促進する新規ドラッグデリバリーシステムの特定に向けた研究の成長

Growing Research in Identification of Novel Drug Delivery Systems will propel the Market for Oral Macromolecule Formulation
出版日: | 発行: Persistence Market Research | ページ情報: 英文 158 Pages | 納期: 2～5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.86円
経口高分子製剤の世界市場：成長を促進する新規ドラッグデリバリーシステムの特定に向けた研究の成長
出版日: 2022年12月29日
発行: Persistence Market Research
ページ情報: 英文 158 Pages
納期: 2～5営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の経口高分子製剤市場について調査し、市場力学、セグメント別および地域別の動向、および企業プロファイルなどの情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場範囲/分類法
  • 市場の定義/範囲/制限
  • 包含と除外

第3章 主要な市場動向

  • 市場に影響を与える主要動向
  • イノベーション/開発動向

第4章 主要な成功要因

  • 採用分析
  • 疾病疫学
  • 主要な規制
  • PESTEL分析
  • 主要なプロモーション戦略：主要企業別

第5章 市場の背景

  • マクロ経済要因
  • 予測要因 - 関連性と影響
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会分析

第6章 COVID-19の危機分析

  • COVID-19と影響分析
    • 適応症別
    • エンドユーザー別
    • 国別
  • 市場シナリオ（2022年）

第7章 世界の経口高分子製剤市場の需要分析と予測

  • 過去の市場分析
  • 現在および将来の市場予測
    • 前年比成長動向分析

第8章 世界の経口高分子製剤市場の分析と予測：適応症別

  • イントロダクション/主要な調査結果
  • 過去の市場分析：適応症別
  • 現在および将来の市場分析と予測：適応症別
    • 炎症性腸疾患
    • 糖尿病
    • その他
  • 市場魅力度分析：適応症別

第9章 世界の経口高分子製剤市場の分析と予測：エンドユーザー別

  • イントロダクション/主要な調査結果
  • 過去の市場分析：エンドユーザー別
  • 現在および将来の市場分析と予測：エンドユーザー別
    • バイオ医薬品企業
    • 学術・研究機関
  • 市場魅力度分析：エンドユーザー別

第10章 世界の経口高分子製剤市場の分析と予測：地域別

  • イントロダクション
  • 過去の市場分析：地域別
  • 現在および将来の市場分析と予測
    • 北米
    • ラテンアメリカ
    • 欧州
    • 東アジア
    • 南アジア
    • オセアニア
    • 中東・アフリカ
  • 市場魅力度分析：地域別

第11章 北米の経口高分子製剤市場の分析と予測

第12章 ラテンアメリカの経口高分子製剤市場の分析と予測

第13章 欧州の経口高分子製剤市場の分析と予測

第14章 東アジアの経口高分子製剤市場の分析と予測

第15章 南アジアの経口高分子製剤市場の分析と予測

第16章 オセアニアの経口高分子製剤市場の分析と予測

第17章 中東・アフリカの経口高分子製剤市場の分析と予測

第18章 市場構造分析

  • 市場分析：企業階層別
  • 主要企業の市場シェア分析
  • 市場プレゼンス分析

第19章 競合分析

  • 競合ダッシュボード
  • 競合の詳細情報
    • Catalent, Inc
    • Diabetology Ltd
    • UPM Pharmaceuticals

第20章 前提条件と使用している頭字語

第21章 調査手法

図表

List of Tables

  • Table 01: Global Oral Macromolecule Formulation Market Analysis 2016-2022 and Forecast 2023-2033 By Indication
  • Table 02: Global Oral Macromolecule Formulation Market Analysis 2016-2022 and Forecast 2023-2033 By End User
  • Table 03: Global Oral Macromolecule Formulation Market Analysis 2016-2022 and Forecast 2023-2033 by Region
  • Table 04: North America Oral Macromolecule Formulation Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033 by Country
  • Table 05: North America Oral Macromolecule Formulation Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033 By Indication
  • Table 06: North America Oral Macromolecule Formulation Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033 By End User
  • Table 07: Latin America Oral Macromolecule Formulation Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033 by Country
  • Table 08: Latin America Oral Macromolecule Formulation Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033 By Indication
  • Table 09: Latin America Oral Macromolecule Formulation Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033 By End User
  • Table 10: Europe Oral Macromolecule Formulation Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033 by Country
  • Table 11: Europe Oral Macromolecule Formulation Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033 By Indication
  • Table 12: Europe Oral Macromolecule Formulation Market Analysis 2016-2022 and Forecast 2023-2033By End User
  • Table 13: East Asia Oral Macromolecule Formulation Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033 by Country
  • Table 14: East Asia Oral Macromolecule Formulation Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033 By Indication
  • Table 15: East Asia Oral Macromolecule Formulation Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033 By End User
  • Table 16: South Asia Oral Macromolecule Formulation Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033 by Country
  • Table 17: South Asia Oral Macromolecule Formulation Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033 By Indication
  • Table 18: South Asia Oral Macromolecule Formulation Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033 By End User
  • Table 19: Oceania Oral Macromolecule Formulation Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033 by Country
  • Table 20: Oceania Oral Macromolecule Formulation Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033 By Indication
  • Table 21: Oceania Oral Macromolecule Formulation Market Analysis 2016-2022 and Forecast 2023-2033By End User
  • Table 22: Middle East & Africa Oral Macromolecule Formulation Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033 by Country
  • Table 23: Middle East & Africa Oral Macromolecule Formulation Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033 By Indication
  • Table 24: Middle East & Africa Oral Macromolecule Formulation Market Analysis 2016-2022 and Forecast 2023-2033 By End User

List of Figures

  • Figure 01: Global Oral Macromolecule Formulation Market Value (US$ Mn) Analysis 2016-2022
  • Figure 02: Global Oral Macromolecule Formulation Market Forecast & Y-o-Y Growth 2023-2033
  • Figure 03: Global Oral Macromolecule Formulation Market Absolute $ Opportunity (US$ Mn) Analysis 2022-2033
  • Figure 04: Global Oral Macromolecule Formulation Market Value Share (%) Analysis 2023 and 2033 By Indication
  • Figure 05: Global Oral Macromolecule Formulation Market Y-o-Y Growth (%) Analysis 2022-2033 By Indication
  • Figure 06: Global Oral Macromolecule Formulation Market Attractiveness Analysis 2023-2033 By Indication
  • Figure 07: Global Oral Macromolecule Formulation Market Value Share (%) Analysis 2023 and 2033 By End User
  • Figure 08: Global Oral Macromolecule Formulation Market Y-o-Y Growth (%) Analysis 2022-2033 By End User
  • Figure 09: Global Oral Macromolecule Formulation Market Attractiveness Analysis 2023-2033 By End User
  • Figure 10: Global Oral Macromolecule Formulation Market Value Share (%) Analysis 2023 and 2033 by Region
  • Figure 11: Global Oral Macromolecule Formulation Market Y-o-Y Growth (%) Analysis 2022-2033 by Region
  • Figure 12: Global Oral Macromolecule Formulation Market Attractiveness Analysis 2023-2033 by Region
  • Figure 13: North America Oral Macromolecule Formulation Market Value (US$ Mn) Analysis 2016-2022
  • Figure 14: North America Oral Macromolecule Formulation Market Value (US$ Mn) Forecast 2023-2033
  • Figure 15: North America Oral Macromolecule Formulation Market Value Share By Indication (2023 E)
  • Figure 16: North America Oral Macromolecule Formulation Market Value Share By End User (2023 E)
  • Figure 17: North America Oral Macromolecule Formulation Market Value Share by Country (2023 E)
  • Figure 18: North America Oral Macromolecule Formulation Market Attractiveness Analysis By Indication 2023-2033
  • Figure 19: North America Oral Macromolecule Formulation Market Attractiveness Analysis by Country 2023-2033
  • Figure 20: U.S. Oral Macromolecule Formulation Market Value Proportion Analysis 2022
  • Figure 21: Global Vs. U.S. Growth Comparison 2022 - 2033
  • Figure 22: U.S. Oral Macromolecule Formulation Market Share Analysis (%) By Indication 2022 & 2033
  • Figure 23: U.S. Oral Macromolecule Formulation Market Share Analysis (%) By End User 2022 & 2033
  • Figure 24: Canada Oral Macromolecule Formulation Market Value Proportion Analysis 2022
  • Figure 25: Global Vs. Canada. Growth Comparison 2022 - 2033
  • Figure 26: Canada Oral Macromolecule Formulation Market Share Analysis (%) By Indication 2022 & 2033
  • Figure 27: Canada Oral Macromolecule Formulation Market Share Analysis (%) By End User 2022 & 2033
  • Figure 28: Latin America Oral Macromolecule Formulation Market Value (US$ Mn) Analysis 2016-2022
  • Figure 29: Latin America Oral Macromolecule Formulation Market Value (US$ Mn) Forecast 2023-2033
  • Figure 30: Latin America Oral Macromolecule Formulation Market Value Share By Indication (2023 E)
  • Figure 31: Latin America Oral Macromolecule Formulation Market Value Share By End User (2023 E)
  • Figure 32: Latin America Oral Macromolecule Formulation Market Value Share by Country (2023 E)
  • Figure 33: Latin America Oral Macromolecule Formulation Market Attractiveness Analysis By Indication 2023-2033
  • Figure 34: Latin America Oral Macromolecule Formulation Market Attractiveness Analysis By End User 2023-2033
  • Figure 35: Latin America Oral Macromolecule Formulation Market Attractiveness Analysis by Country 2023-2033
  • Figure 36: Mexico Oral Macromolecule Formulation Market Value Proportion Analysis 2022
  • Figure 37: Global Vs Mexico Growth Comparison 2022 - 2033
  • Figure 38: Mexico Oral Macromolecule Formulation Market Share Analysis (%) By Indication 2022 & 2033
  • Figure 39: Mexico Oral Macromolecule Formulation Market Share Analysis (%) By End User 2022 & 2033
  • Figure 40: Brazil Oral Macromolecule Formulation Market Value Proportion Analysis 2022
  • Figure 41: Global Vs. Brazil. Growth Comparison 2022 - 2033
  • Figure 42: Brazil Oral Macromolecule Formulation Market Share Analysis (%) By Indication 2022 & 2033
  • Figure 43: Brazil Oral Macromolecule Formulation Market Share Analysis (%) By End User 2022 & 2033
  • Figure 44: Argentina Oral Macromolecule Formulation Market Value Proportion Analysis 2022
  • Figure 45: Global Vs Argentina Growth Comparison 2022 - 2033
  • Figure 46: Argentina Oral Macromolecule Formulation Market Share Analysis (%) By Indication 2022 & 2033
  • Figure 47: Argentina Oral Macromolecule Formulation Market Share Analysis (%) By End User 2022 & 2033
  • Figure 48: Europe Oral Macromolecule Formulation Market Value (US$ Mn) Analysis 2016-2022
  • Figure 49: Europe Oral Macromolecule Formulation Market Value (US$ Mn) Forecast 2023-2033
  • Figure 50: Europe Oral Macromolecule Formulation Market Value Share By Indication (2023 E)
  • Figure 51: Europe Oral Macromolecule Formulation Market Value Share By End User (2023 E)
  • Figure 52: Europe Oral Macromolecule Formulation Market Value Share by Country (2023 E)
  • Figure 53: Europe Oral Macromolecule Formulation Market Attractiveness Analysis By Indication 2023-2033
  • Figure 54: Europe Oral Macromolecule Formulation Market Attractiveness Analysis By End User 2023-2033
  • Figure 55: Europe Oral Macromolecule Formulation Market Attractiveness Analysis by Country 2023-2033
  • Figure 56: UK Oral Macromolecule Formulation Market Value Proportion Analysis 2022
  • Figure 57: Global Vs. UK Growth Comparison 2022 - 2033
  • Figure 58: UK Oral Macromolecule Formulation Market Share Analysis (%) By Indication 2022 & 2033
  • Figure 59: UK Oral Macromolecule Formulation Market Share Analysis (%) By End User 2022 & 2033
  • Figure 60: Germany Oral Macromolecule Formulation Market Value Proportion Analysis 2022
  • Figure 61: Global Vs. Germany Growth Comparison 2022 - 2033
  • Figure 62: Germany Oral Macromolecule Formulation Market Share Analysis (%) By Indication 2022 & 2033
  • Figure 63: Germany Oral Macromolecule Formulation Market Share Analysis (%) By End User 2022 & 2033
  • Figure 64: Italy Oral Macromolecule Formulation Market Value Proportion Analysis 2022
  • Figure 65: Global Vs. Italy Growth Comparison 2022 - 2033
  • Figure 66: Italy Oral Macromolecule Formulation Market Share Analysis (%) By Indication 2022 & 2033
  • Figure 67: Italy Oral Macromolecule Formulation Market Share Analysis (%) By End User 2022 & 2033
  • Figure 68: France Oral Macromolecule Formulation Market Value Proportion Analysis 2022
  • Figure 69: Global Vs France Growth Comparison 2022 - 2033
  • Figure 70: France Oral Macromolecule Formulation Market Share Analysis (%) By Indication 2022 & 2033
  • Figure 71: France Oral Macromolecule Formulation Market Share Analysis (%) By End User 2022 & 2033
  • Figure 72: Spain Oral Macromolecule Formulation Market Value Proportion Analysis 2022
  • Figure 73: Global Vs Spain Growth Comparison 2022 - 2033
  • Figure 74: Spain Oral Macromolecule Formulation Market Share Analysis (%) By Indication 2022 & 2033
  • Figure 75: Spain Oral Macromolecule Formulation Market Share Analysis (%) By End User 2022 & 2033
  • Figure 76: Russia Oral Macromolecule Formulation Market Value Proportion Analysis 2022
  • Figure 77: Global Vs Russia Growth Comparison 2022 - 2033
  • Figure 78: Russia Oral Macromolecule Formulation Market Share Analysis (%) By Indication 2022 & 2033
  • Figure 79: Russia Oral Macromolecule Formulation Market Share Analysis (%) By End User 2022 & 2033
  • Figure 80: BENELUX Oral Macromolecule Formulation Market Value Proportion Analysis 2022
  • Figure 81: Global Vs BENELUX Growth Comparison 2022 - 2033
  • Figure 82: BENELUX Oral Macromolecule Formulation Market Share Analysis (%) By Indication 2022 & 2033
  • Figure 83: BENELUX Oral Macromolecule Formulation Market Share Analysis (%) By End User 2022 & 2033
  • Figure 84: East Asia Oral Macromolecule Formulation Market Value (US$ Mn) Analysis 2016-2022
  • Figure 85: East Asia Oral Macromolecule Formulation Market Value (US$ Mn) Forecast 2023-2033
  • Figure 86: East Asia Oral Macromolecule Formulation Market Value Share By Indication (2023 E)
  • Figure 87: East Asia Oral Macromolecule Formulation Market Value Share By End User (2023 E)
  • Figure 88: East Asia Oral Macromolecule Formulation Market Value Share by Country (2023 E)
  • Figure 89: East Asia Oral Macromolecule Formulation Market Attractiveness Analysis By Indication 2023-2033
  • Figure 90: East Asia Oral Macromolecule Formulation Market Attractiveness Analysis By End User 2023-2033
  • Figure 91: East Asia Oral Macromolecule Formulation Market Attractiveness Analysis by Country 2023-2033
  • Figure 92: China Oral Macromolecule Formulation Market Value Proportion Analysis 2022
  • Figure 93: Global Vs. China Growth Comparison 2022 - 2033
  • Figure 94: China Oral Macromolecule Formulation Market Share Analysis (%) By Indication 2022 & 2033
  • Figure 95: China Oral Macromolecule Formulation Market Share Analysis (%) By End User 2022 & 2033
  • Figure 96: Japan Oral Macromolecule Formulation Market Value Proportion Analysis 2022
  • Figure 97: Global Vs. Japan Growth Comparison 2022 - 2033
  • Figure 98: Japan Oral Macromolecule Formulation Market Share Analysis (%) By Indication 2022 & 2033
  • Figure 99: Japan Oral Macromolecule Formulation Market Share Analysis (%) By End User 2022 & 2033
  • Figure 100: South Korea Oral Macromolecule Formulation Market Value Proportion Analysis 2022
  • Figure 101: Global Vs South Korea Growth Comparison 2022 - 2033
  • Figure 102: South Korea Oral Macromolecule Formulation Market Share Analysis (%) By Indication 2022 & 2033
  • Figure 103: South Korea Oral Macromolecule Formulation Market Share Analysis (%) By End User 2022 & 2033
  • Figure 104: South Asia Oral Macromolecule Formulation Market Value (US$ Mn) Analysis 2016-2022
  • Figure 105: South Asia Oral Macromolecule Formulation Market Value (US$ Mn) Forecast 2023-2033
  • Figure 106: South Asia Oral Macromolecule Formulation Market Value Share By Indication (2023 E)
  • Figure 107: South Asia Oral Macromolecule Formulation Market Value Share By End User (2023 E)
  • Figure 108: South Asia Oral Macromolecule Formulation Market Value Share by Country (2023 E)
  • Figure 109: South Asia Oral Macromolecule Formulation Market Attractiveness Analysis By Indication 2023-2033
  • Figure 110: South Asia Oral Macromolecule Formulation Market Attractiveness Analysis By End User 2023-2033
  • Figure 111: South Asia Oral Macromolecule Formulation Market Attractiveness Analysis by Country 2023-2033
  • Figure 112: India Oral Macromolecule Formulation Market Value Proportion Analysis 2022
  • Figure 113: Global Vs. India Growth Comparison 2022 - 2033
  • Figure 114: India Oral Macromolecule Formulation Market Share Analysis (%) By Indication 2022 & 2033
  • Figure 115: India Oral Macromolecule Formulation Market Share Analysis (%) By End User 2022 & 2033
  • Figure 116: Indonesia Oral Macromolecule Formulation Market Value Proportion Analysis 2022
  • Figure 117: Global Vs. Indonesia Growth Comparison 2022 - 2033
  • Figure 118: Indonesia Oral Macromolecule Formulation Market Share Analysis (%) By Indication 2022 & 2033
  • Figure 119: Indonesia Oral Macromolecule Formulation Market Share Analysis (%) By End User 2022 & 2033
  • Figure 120: Malaysia Oral Macromolecule Formulation Market Value Proportion Analysis 2022
  • Figure 121: Global Vs. Malaysia Growth Comparison 2022 - 2033
  • Figure 122: Malaysia Oral Macromolecule Formulation Market Share Analysis (%) By Indication 2022 & 2033
  • Figure 123: Malaysia Oral Macromolecule Formulation Market Share Analysis (%) By End User 2022 & 2033
  • Figure 124: Thailand Oral Macromolecule Formulation Market Value Proportion Analysis 2022
  • Figure 125: Global Vs. Thailand Growth Comparison 2022 - 2033
  • Figure 126: Thailand Oral Macromolecule Formulation Market Share Analysis (%) By Indication 2022 & 2033
  • Figure 127: Thailand Oral Macromolecule Formulation Market Share Analysis (%) By End User 2022 & 2033
  • Figure 128: Oceania Oral Macromolecule Formulation Market Value (US$ Mn) Analysis 2016-2022
  • Figure 129: Oceania Oral Macromolecule Formulation Market Value (US$ Mn) Forecast 2023-2033
  • Figure 130: Oceania Oral Macromolecule Formulation Market Value Share By Indication (2023 E)
  • Figure 131: Oceania Oral Macromolecule Formulation Market Value Share By End User (2023 E)
  • Figure 132: Oceania Oral Macromolecule Formulation Market Value Share by Country (2023 E)
  • Figure 133: Oceania Oral Macromolecule Formulation Market Attractiveness Analysis By Indication 2023-2033
  • Figure 134: Oceania Oral Macromolecule Formulation Market Attractiveness Analysis By End User 2023-2033
  • Figure 135: Oceania Oral Macromolecule Formulation Market Attractiveness Analysis by Country 2023-2033
  • Figure 136: Australia Oral Macromolecule Formulation Market Value Proportion Analysis 2022
  • Figure 137: Global Vs. Australia Growth Comparison 2022 - 2033
  • Figure 138: Australia Oral Macromolecule Formulation Market Share Analysis (%) By Indication 2022 & 2033
  • Figure 139: Australia Oral Macromolecule Formulation Market Share Analysis (%) By End User 2022 & 2033
  • Figure 140: New Zealand Oral Macromolecule Formulation Market Value Proportion Analysis 2022
  • Figure 141: Global Vs New Zealand Growth Comparison 2022 - 2033
  • Figure 142: New Zealand Oral Macromolecule Formulation Market Share Analysis (%) By Indication 2022 & 2033
  • Figure 143: New Zealand Oral Macromolecule Formulation Market Share Analysis (%) By End User 2022 & 2033
  • Figure 144: Middle East & Africa Oral Macromolecule Formulation Market Value (US$ Mn) Analysis 2016-2022
  • Figure 145: Middle East & Africa Oral Macromolecule Formulation Market Value (US$ Mn) Forecast 2023-2033
  • Figure 146: Middle East & Africa Oral Macromolecule Formulation Market Value Share By Indication (2023 E)
  • Figure 147: Middle East & Africa Oral Macromolecule Formulation Market Value Share By End User (2023 E)
  • Figure 148: Middle East & Africa Oral Macromolecule Formulation Market Value Share by Country (2023 E)
  • Figure 149: Middle East & Africa Oral Macromolecule Formulation Market Attractiveness Analysis By Indication 2023-2033
  • Figure 150: Middle East & Africa Oral Macromolecule Formulation Market Attractiveness Analysis By End User 2023-2033
  • Figure 151: Middle East & Africa Oral Macromolecule Formulation Market Attractiveness Analysis by Country 2023-2033
  • Figure 152: GCC Countries Oral Macromolecule Formulation Market Value Proportion Analysis 2022
  • Figure 153: Global Vs GCC Countries Growth Comparison 2022 - 2033
  • Figure 154: GCC Countries Oral Macromolecule Formulation Market Share Analysis (%) By Indication 2022 & 2033
  • Figure 155: GCC Countries Oral Macromolecule Formulation Market Share Analysis (%) By End User 2022 & 2033
  • Figure 156: Turkey Oral Macromolecule Formulation Market Value Proportion Analysis 2022
  • Figure 157: Global Vs. Turkey Growth Comparison 2022 - 2033
  • Figure 158: Turkey Oral Macromolecule Formulation Market Share Analysis (%) By Indication 2022 & 2033
  • Figure 159: Turkey Oral Macromolecule Formulation Market Share Analysis (%) By End User 2022 & 2033
  • Figure 160: South Africa Oral Macromolecule Formulation Market Value Proportion Analysis 2022
  • Figure 161: Global Vs. South Africa Growth Comparison 2022 - 2033
  • Figure 162: South Africa Oral Macromolecule Formulation Market Share Analysis (%) By Indication 2022 & 2033
  • Figure 163: South Africa Oral Macromolecule Formulation Market Share Analysis (%) By End User 2022 & 2033
  • Figure 164: North Africa Oral Macromolecule Formulation Market Value Proportion Analysis 2022
  • Figure 165: Global Vs North Africa Growth Comparison 2022 - 2033
  • Figure 166: North Africa Oral Macromolecule Formulation Market Share Analysis (%) By Indication 2022 & 2033
  • Figure 167: North Africa Oral Macromolecule Formulation Market Share Analysis (%) By End User 2022 & 2033
目次
Product Code: PMRREP32388

Oral Macromolecule Formulation Market: Scope of the Report

The latest publication by Persistence Market Research on the global oral macromolecule formulation market evaluates the opportunities and current market landscape and provides detailed analysis, and updates about corresponding sections affecting the market. The study offers detailed insights on current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2023-2033.

Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research's study. This research study can support readers to know the demand for oral macromolecule formulations and the quantitative development opportunities during the study period.

The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the oral macromolecule formulation market. Shareholders in the oral macromolecule formulation market, industry experts, investors, researchers, and reporters, as well as business enthusiasts can leverage insights and information presented in this Persistence Market Research study.

Market statistics, as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the oral macromolecule formulation market, are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.

Key Market Segments

Persistence Market Research's study on the oral macromolecule formulation market offers information divided into three important segments - indication, end user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Indication

Inflammatory Bowel Disorder

Crohn's Disease

Ulcerative Colitis

Diabetes

Others

End User

Biopharmaceutical Companies

Academic and Research Institutes

Region

North America

Latin America

Europe

South Asia

East Asia

Oceania

Middle East and Africa (MEA)

Key Questions Answered in Report:

Which regions will continue to remain the most profitable markets for oral macromolecule formulation over the coming years?

How will changing trends influence the market?

How has the COVID-19 crisis influenced market growth?

How can market players capture the low-hanging opportunities in developed regions?

What are the strategies of stakeholders in the market to shape their position in this landscape?

What are the restraining factors that investors need to be aware of and might tackle while investing in the market?

What are the developmental trends that will influence the market?

How can companies in the oral macromolecule formulation market avail themselves the growth opportunities in developed and emerging sectors?

Research Methodology

In Persistence Market Research's study, a unique research methodology is utilized to conduct extensive research on the growth of the oral macromolecule formulation market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts to ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market, and makes Persistence Market Research's projections on the growth prospects of the oral macromolecule formulation market are more accurate and reliable.

Table of Contents

 1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Innovation / Development Trends

4. Key Success Factors

  • 4.1. Adoption Analysis
  • 4.2. Disease Epidemiology
  • 4.3. Key Regulations
  • 4.4. PESTEL Analysis
  • 4.5. Key Promotional Strategies, By Key Players

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Outlook
    • 5.1.3. Global Oral Proteins and Peptides Market Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Increase in R&D Spending
    • 5.2.2. Growing Disease Prevalence
    • 5.2.3. Cost of Formulations
    • 5.2.4. Growing Demand in Biopharma Firms
    • 5.2.5. Changes in Regulatory Policies
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Indication
    • 6.1.2. By End User
    • 6.1.3. By Country
  • 6.2. 2022 Market Scenario

7. Global Oral Macromolecule Formulation Market Demand (in Value or Size in US$ Mn) Analysis 2016-2022 and Forecast, 2023-2033

  • 7.1. Historical Market Value (US$ Mn) Analysis, 2016-2022
  • 7.2. Current and Future Market Value (US$ Mn) Projections, 2023-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Oral Macromolecule Formulation Market Analysis 2016-2022 and Forecast 2023-2033, By Indication

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) Analysis By Indication, 2016-2022
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2023-2033
    • 8.3.1. Inflammatory Bowel Disorder
      • 8.3.1.1. Crohn's Disease
      • 8.3.1.2. Ulcerative Colitis
    • 8.3.2. Diabetes
    • 8.3.3. Others
  • 8.4. Market Attractiveness Analysis By Indication

9. Global Oral Macromolecule Formulation Market Analysis 2016-2022 and Forecast 2023-2033, By End User

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) Analysis, By End User, 2016-2022
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2023-2033
    • 9.3.1. Biopharmaceutical Companies
    • 9.3.2. Academic and Research Institutes
  • 9.4. Market Attractiveness Analysis By End User

10. Global Oral Macromolecule Formulation Market Analysis 2016-2022 and Forecast 2023-2033, By Region

  • 10.1. Introduction
  • 10.2. Historical Market Size (US$ Mn) Analysis By Region, 2016-2022
  • 10.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, 2023-2033
    • 10.3.1. North America
    • 10.3.2. Latin America
    • 10.3.3. Europe
    • 10.3.4. East Asia
    • 10.3.5. South Asia
    • 10.3.6. Oceania
    • 10.3.7. Middle East and Africa (MEA)
  • 10.4. Market Attractiveness Analysis By Region

11. North America Oral Macromolecule Formulation Market Analysis 2016-2022 and Forecast 2023-2033

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2022
  • 11.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2023-2033
    • 11.3.1. By Country
      • 11.3.1.1. U.S.
      • 11.3.1.2. Canada
    • 11.3.2. By Indication
    • 11.3.3. By End User
  • 11.4. Market Attractiveness Analysis
    • 11.4.1. By Country
    • 11.4.2. By Indication
    • 11.4.3. By End User
  • 11.5. Market Trends
  • 11.6. Drivers and Restraints - Impact Analysis
  • 11.7. Key Players - Intensity Mapping
  • 11.8. Country Level Analysis & Forecast
    • 11.8.1. U.S. Oral Macromolecule Formulation Market Analysis
      • 11.8.1.1. Introduction
      • 11.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 11.8.1.2.1. By Indication
        • 11.8.1.2.2. By End User
    • 11.8.2. Canada Oral Macromolecule Formulation Market Analysis
      • 11.8.2.1. Introduction
      • 11.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 11.8.2.2.1. By Indication
        • 11.8.2.2.2. By End User

12. Latin America Oral Macromolecule Formulation Market Analysis 2016-2022 and Forecast 2023-2033

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2022
  • 12.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2023-2033
    • 12.3.1. By Country
      • 12.3.1.1. Mexico
      • 12.3.1.2. Brazil
      • 12.3.1.3. Argentina
      • 12.3.1.4. Rest of Latin America
    • 12.3.2. By Indication
    • 12.3.3. By End User
  • 12.4. Market Attractiveness Analysis
    • 12.4.1. By Country
    • 12.4.2. By Indication
    • 12.4.3. By End User
  • 12.5. Market Trends
  • 12.6. Drivers and Restraints - Impact Analysis
  • 12.7. Key Players - Intensity Mapping
  • 12.8. Country Level Analysis & Forecast
    • 12.8.1. Mexico Oral Macromolecule Formulation Market Analysis
      • 12.8.1.1. Introduction
      • 12.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 12.8.1.2.1. By Indication
        • 12.8.1.2.2. By End User
    • 12.8.2. Brazil Oral Macromolecule Formulation Market Analysis
      • 12.8.2.1. Introduction
      • 12.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 12.8.2.2.1. By Indication
        • 12.8.2.2.2. By End User
    • 12.8.3. Argentina Oral Macromolecule Formulation Market Analysis
      • 12.8.3.1. Introduction
      • 12.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 12.8.3.2.1. By Indication
        • 12.8.3.2.2. By End User

13. Europe Oral Macromolecule Formulation Market Analysis 2016-2022 and Forecast 2023-2033

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2022
  • 13.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2023-2033
    • 13.3.1. By Country
      • 13.3.1.1. Germany
      • 13.3.1.2. Italy
      • 13.3.1.3. France
      • 13.3.1.4. U.K.
      • 13.3.1.5. Spain
      • 13.3.1.6. BENELUX
      • 13.3.1.7. Russia
      • 13.3.1.8. Rest of Europe
    • 13.3.2. By Indication
    • 13.3.3. By End User
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Indication
    • 13.4.3. By End User
  • 13.5. Market Trends
  • 13.6. Drivers and Restraints - Impact Analysis
  • 13.7. Key Players - Intensity Mapping
  • 13.8. Country Level Analysis & Forecast
    • 13.8.1. Germany Oral Macromolecule Formulation Market Analysis
      • 13.8.1.1. Introduction
      • 13.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.1.2.1. By Indication
        • 13.8.1.2.2. By End User
    • 13.8.2. Italy Oral Macromolecule Formulation Market Analysis
      • 13.8.2.1. Introduction
      • 13.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.2.2.1. By Indication
        • 13.8.2.2.2. By End User
    • 13.8.3. France Oral Macromolecule Formulation Market Analysis
      • 13.8.3.1. Introduction
      • 13.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.3.2.1. By Indication
        • 13.8.3.2.2. By End User
    • 13.8.4. U.K. Oral Macromolecule Formulation Market Analysis
      • 13.8.4.1. Introduction
      • 13.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.4.2.1. By Indication
        • 13.8.4.2.2. By End User
    • 13.8.5. Spain Oral Macromolecule Formulation Market Analysis
      • 13.8.5.1. Introduction
      • 13.8.5.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.5.2.1. By Indication
        • 13.8.5.2.2. By End User
    • 13.8.6. BENELUX Oral Macromolecule Formulation Market Analysis
      • 13.8.6.1. Introduction
      • 13.8.6.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.6.2.1. By Indication
        • 13.8.6.2.2. By End User
    • 13.8.7. Russia Oral Macromolecule Formulation Market Analysis
      • 13.8.7.1. Introduction
      • 13.8.7.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.7.2.1. By Indication
        • 13.8.7.2.2. By End User

14. East Asia Oral Macromolecule Formulation Market Analysis 2016-2022 and Forecast 2023-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2022
  • 14.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2023-2033
    • 14.3.1. By Country
      • 14.3.1.1. China
      • 14.3.1.2. Japan
      • 14.3.1.3. South Korea
    • 14.3.2. By Indication
    • 14.3.3. By End User
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Indication
    • 14.4.3. By End User
  • 14.5. Market Trends
  • 14.6. Drivers and Restraints - Impact Analysis
  • 14.7. Key Players - Intensity Mapping
  • 14.8. Country Level Analysis & Forecast
    • 14.8.1. China Oral Macromolecule Formulation Market Analysis
      • 14.8.1.1. Introduction
      • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.1.2.1. By Indication
        • 14.8.1.2.2. By End User
    • 14.8.2. Japan Oral Macromolecule Formulation Market Analysis
      • 14.8.2.1. Introduction
      • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.2.2.1. By Indication
        • 14.8.2.2.2. By End User
    • 14.8.3. South Korea Oral Macromolecule Formulation Market Analysis
      • 14.8.3.1. Introduction
      • 14.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.3.2.1. By Indication
        • 14.8.3.2.2. By End User

15. South Asia Oral Macromolecule Formulation Market Analysis 2016-2022 and Forecast 2023-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2022
  • 15.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2023-2033
    • 15.3.1. By Country
      • 15.3.1.1. India
      • 15.3.1.2. Indonesia
      • 15.3.1.3. Malaysia
      • 15.3.1.4. Thailand
      • 15.3.1.5. Rest of South Asia
    • 15.3.2. By Indication
    • 15.3.3. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Indication
    • 15.4.3. By End User
  • 15.5. Market Trends
  • 15.6. Drivers and Restraints - Impact Analysis
  • 15.7. Key Players - Intensity Mapping
  • 15.8. Country Level Analysis & Forecast
    • 15.8.1. India Oral Macromolecule Formulation Market Analysis
      • 15.8.1.1. Introduction
      • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.1.2.1. By Indication
        • 15.8.1.2.2. By End User
    • 15.8.2. Indonesia Oral Macromolecule Formulation Market Analysis
      • 15.8.2.1. Introduction
      • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.2.2.1. By Indication
        • 15.8.2.2.2. By End User
    • 15.8.3. Malaysia Oral Macromolecule Formulation Market Analysis
      • 15.8.3.1. Introduction
      • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.3.2.1. By Indication
        • 15.8.3.2.2. By End User
    • 15.8.4. Thailand Oral Macromolecule Formulation Market Analysis
      • 15.8.4.1. Introduction
      • 15.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.4.2.1. By Indication
        • 15.8.4.2.2. By End User

16. Oceania Oral Macromolecule Formulation Market 2016-2023 and Forecast 2023-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2022
  • 16.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2023-2033
    • 16.3.1. By Country
      • 16.3.1.1. Australia
      • 16.3.1.2. New Zealand
    • 16.3.2. By Indication
    • 16.3.3. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Indication
    • 16.4.3. By End User
  • 16.5. Market Trends
  • 16.6. Drivers and Restraints - Impact Analysis
  • 16.7. Key Players - Intensity Mapping
  • 16.8. Country Level Analysis & Forecast
    • 16.8.1. Australia Oral Macromolecule Formulation Market Analysis
      • 16.8.1.1. Introduction
      • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.1.2.1. By Indication
        • 16.8.1.2.2. By End User
    • 16.8.2. New Zealand Oral Macromolecule Formulation Market Analysis
      • 16.8.2.1. Introduction
      • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.2.2.1. By Indication
        • 16.8.2.2.2. By End User

17. Middle East and Africa (MEA) Oral Macromolecule Formulation Market Analysis 2016-2022 and Forecast 2023-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2022
  • 17.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2023-2033
    • 17.3.1. By Country
      • 17.3.1.1. GCC Countries
      • 17.3.1.2. Turkey
      • 17.3.1.3. North Africa
      • 17.3.1.4. South Africa
      • 17.3.1.5. Rest of Middle East and Africa
    • 17.3.2. By Indication
    • 17.3.3. By End User
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Indication
    • 17.4.3. By End User
  • 17.5. Market Trends
  • 17.6. Drivers and Restraints - Impact Analysis
  • 17.7. Key Players - Intensity Mapping
  • 17.8. Country Level Analysis & Forecast
    • 17.8.1. GCC Countries Oral Macromolecule Formulation Market Analysis
      • 17.8.1.1. Introduction
      • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.1.2.1. By Indication
        • 17.8.1.2.2. By End User
    • 17.8.2. Turkey Oral Macromolecule Formulation Market Analysis
      • 17.8.2.1. Introduction
      • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.2.2.1. By Indication
        • 17.8.2.2.2. By End User
    • 17.8.3. South Africa Oral Macromolecule Formulation Market Analysis
      • 17.8.3.1. Introduction
      • 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.3.2.1. By Indication
        • 17.8.3.2.2. By End User
    • 17.8.4. North Africa Oral Macromolecule Formulation Market Analysis
      • 17.8.4.1. Introduction
      • 17.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.4.2.1. By Indication
        • 17.8.4.2.2. By End User

18. Market Structure Analysis

  • 18.1. Market Analysis by Tier of Companies
  • 18.2. Market Share Analysis of Top Players
  • 18.3. Market Presence Analysis

19. Competition Analysis

  • 19.1. Competition Dashboard
  • 19.2. Competition Deep Dive
    • 19.2.1. Catalent, Inc
      • 19.2.1.1. Overview
      • 19.2.1.2. Portfolio
      • 19.2.1.3. Sales Footprint
      • 19.2.1.4. Key Financials
      • 19.2.1.5. SWOT Analysis
      • 19.2.1.6. Strategy Overview
        • 19.2.1.6.1. Marketing Strategy
        • 19.2.1.6.2. Channel Strategy
    • 19.2.2. Diabetology Ltd
      • 19.2.2.1. Overview
      • 19.2.2.2. Portfolio
      • 19.2.2.3. Sales Footprint
      • 19.2.2.4. Key Financials
      • 19.2.2.5. SWOT Analysis
      • 19.2.2.6. Strategy Overview
        • 19.2.2.6.1. Marketing Strategy
        • 19.2.2.6.2. Channel Strategy
    • 19.2.3. UPM Pharmaceuticals
      • 19.2.3.1. Overview
      • 19.2.3.2. Portfolio
      • 19.2.3.3. Sales Footprint
      • 19.2.3.4. Key Financials
      • 19.2.3.5. SWOT Analysis
      • 19.2.3.6. Strategy Overview
        • 19.2.3.6.1. Marketing Strategy
        • 19.2.3.6.2. Channel Strategy

20. Assumptions and Acronyms Used

21. Research Methodology